Daclatasvir plus sofosbuvir regimen sheds promising light on future hepatitis C virus genotype 3 therapies
Main Article Content
Ali Murat Kahveci
Division of Gastroenterology and Hepatology, University of Missouri, Columbia, Missouri, USA
Veysel Tahan
Division of Gastroenterology and Hepatology, University of Missouri, Columbia, Missouri, USA
Abstract
-
Article Details
Article Sidebar
Gastroenterology Elsewhere
Published:
Jul 25, 2019
Keywords:
AVES Editorial Office
How to Cite
Ali Murat Kahveci, & Veysel Tahan. (2019). Daclatasvir plus sofosbuvir regimen sheds promising light on future hepatitis C virus genotype 3 therapies . Turkish Journal of Gastroenterology, 27(1), 89–90. Retrieved from https://tjg.avesjournals.com/index.php/tjg/article/view/3228
Main Article Content
Ali Murat Kahveci
Division of Gastroenterology and Hepatology, University of Missouri, Columbia, Missouri, USA
Veysel Tahan
Division of Gastroenterology and Hepatology, University of Missouri, Columbia, Missouri, USA